Michaelson Jennifer's Form 4 filing
Cullinan Therapeutics, Inc. (CGEM) · filed Feb 23, 2026
- Accession no.
- 0001193125-26-064256
- Filed
- Feb 23, 2026
- Trade date
- Feb 20, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $165.4K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Michaelson JenniferCIK 0001838061 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Common Stock | SSaleDisposed | −3,742 | $13.62 | −$50,966.04 | 181,977 | Direct | |
| Feb 20, 2026 | Common Stock | MOption exerciseAcquired | +8,000 | $4.30 | +$34,400 | 189,977 | Direct | |
| Feb 20, 2026 | Common Stock | SSaleDisposed | −8,000 | $14.30 | −$114,400 | 181,977 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Common Stock | MOption exerciseDisposed | −8,000 | $0.00 | $0 | 124,987 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.